Analyst consensus rating

Odyssey Therapeutics Analyst Rating: Strong Buy

Direct answer

Odyssey Therapeutics's consensus rating is Strong Buy.

6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $34.67.
Forecast evidence checked November 16, 2026.

Get free Odyssey Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$19.14
Average price target
$34.67
High price target
$42.00
Low price target
$27.00
Low target gap
+41.1%
Target upside
+81.1%
High target gap
+119.4%
Target range width
78.4%
Consensus rating
Strong Buy
Analysts
6
Evidence date
November 16, 2026
Valid through
November 23, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Odyssey Therapeutics?

Odyssey Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $34.67.

How far are Odyssey Therapeutics's low and high targets from the recorded price?

The low target implies +41.1%, while the high target implies +119.4%.

How many analysts are included in Odyssey Therapeutics's consensus?

The verified consensus includes 6 analysts.

How is Odyssey Therapeutics's target upside or downside calculated?

The average target of $34.67 is divided by the recorded price of $19.14, then one is subtracted to produce +81.1%. This does not guarantee a future return.

When was Odyssey Therapeutics's analyst forecast verified?

The data was verified on 2026-11-16. The dataset is valid through 2026-11-23.